private-startup · clinical-grade · research-grade
Beacon Biosignals
At a glance
- Legal name
- Beacon Biosignals, Inc.
- Aliases
- —
- Type
- private-startup
- Focus areas
- clinical-grade, research-grade, data-platform, diagnostic
- Founded
- —
- Defunct
- —
- Spinout of
- —
- HQ city
- Boston
- HQ country
- US
- Employees
- —
- Flagship device
- dreem-3
- Product lines
- 1
- In-house manufacturing
- Yes
- Open source
- No
- GitHub org
- —
- Website
- beacon.bio
- Blog
- —
- Support
- —
Devices
People
Current leadership
Jacob Donoghue
CEO
Milestones
Acquires Dreem R&D business from Rythm
FDA 510(k) K223539 for Dreem 3S
Reputation
EEG-analytics + hardware platform pitched at pharma sleep trials. Inherited Dreem's hardware and dataset; rebranded the Dreem 3S as Waveband in 2025.